To discuss Corporate Partnerships, Additional Sponsorship Opportunities, unique fundraising ideas or more about the Walk, and other ways you can be involved please email our Event Director or call 866-PUW-WALK (789-9255).
Sponsors for the 2016 Walk:
DOUBLE DIAMOND SPONSOR
|AbbVie is dedicated to being a partner and champion in the fight against Parkinson’s and we are pleased to join you in support of the 2015 Parkinson’s Unity Walk. AbbVie is committed to improving the lives of those with Parkinson’s and we look forward to continuing our work with the Parkinson’s community to help raise awareness of this disease and funds for research. Thank you to everyone working together in the fight for a better future for patients living with Parkinson’s disease. Read more.|
|Acorda is proud to support the Parkinson’s Unity Walk, and we are excited to join people with Parkinson’s, and their family and friends in April to raise awareness of Parkinson’s. As an emerging leader in Parkinson’s disease therapeutic development, our goal is to support the Parkinson’s community through medical research, educational initiatives and programs like the Unity Walk that collectively help people with Parkinson’s live well. Read more…||Lundbeck proudly supports the Parkinson’s Unity Walk, and we look forward to walking alongside the Parkinson’s disease community in April! We are a global pharmaceutical company with a mission to help people living with brain disorders, including Parkinson’s disease. To learn more, visit us at www.LundbeckUS.com and connect with us on Twitter at @LundbeckUS. Read more.|
|At UCB, we have a passionate, long-term commitment to discovering and developing innovative medicines that transform the lives of people living with severe immunological diseases and central nervous system disorders. With 8,500 employees in 40 countries, we invest more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. Read more.||At US WorldMeds, we hold a fundamental belief that our science has the potential to improve the lives of Parkinson’s patients. US WorldMeds’ commitment to Parkinson’s patients is reflected in all that we do. Our pipeline of development projects, along with our currently available PD treatment, reflects our resolve to bring innovative solutions to Parkinson’s patients. Read more.|
|Details coming soon. Read more.||Great Lakes NeuroTech is passionate about improving quality of life for individuals dealing with Parkinson’s disease. Our team has developed Kinesia wearable sensors, mobile apps and web applications that can help clinicians and patients track how different activities and therapies impact Parkinson’s symptoms. Kinesia technology has been validated for measuring Parkinson’s disease in numerous scientific publications and is used around the world for clinical trials and patient care applications such medication adjustments and programming deep brain stimulation. Read more.|
LSVT Global is a socially responsible business with a mission to empower people with Parkinson disease (PD) through evidence-based speech, physical and occupational therapy programs. LSVT Global seeks to translate clinical treatment research directly to public health practice and increase accessibility of LSVT to people living with PD. Read more.
|Merz North America is dedicated to delivering a better total experience in aesthetics, dermatology and neurosciences. . Merz Neurosciences is an important contributor to the U.S. neurosciences space, offering a well-balanced product portfolio that includes the neurotoxin Xeomin® (incobotulinumtoxinA), the anticholinergic Cuvposa™ (glycopyrrolate) Oral Solution and the Prolaryn™ family of products. Read more.|
|Rare Patient Voice invites Parkinson’s patients and their caregivers to take part in confidential surveys that help companies develop and improve new treatments and services. Those who sign at the Walk will receive a $10 gift card of their choice via email. Read more.||St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases by developing cost-effective medical technologies that save and improve lives of patients around the world. Read more…
Teva CNS is committed to the continued research and development of its product portfolio and to the development of medicines aimed at meeting the specific needs of the patient communities it serves. Teva’s legacy in CNS is grounded in its commitment to ongoing collaboration with academia, medical institutions and patient advocacy groups to find innovative solutions for patients who live with chronic and debilitating diseases, such as Parkinson’s disease. Read more.
Charles and Vivian Sukenik Philanthropic Fund
The Kenneth Aidekman Family Foundation
IN KIND SPONSORS
TEAM PHOTO SPONSOR
We also thank:
|City of New York Parks & Recreation and The New York City Police Department|